Counterfeiter of Tagamet, Naprosyn sentenced
On May 7, in Los Angeles Federal Court Javid Naghdi was sentenced to 14 years of incarceration for "his scheme to sell millions of counterfeit drugs," according to FDA's March/April Case News. In 1987, he and three others (the "Naghdi Group") were convicted of selling counterfeit Naprosyn, but Naghdi fled the country before being sentenced ("The Pink Sheet" Sept. 14, T&G-9). He was later apprehended, extradited and sentenced to five years in jail. Naghdi was then "tried and convicted on nine counts of wire fraud for offering one million bottles of Tagamet to an undercover agent for $28 mil."
You may also be interested in...
Vacci Prep is first “supplement to establish a standard of care for consumers when preparing their immune system for vaccinations,” Dentovations says.
Effective medical device regulation supports both safety and innovation needs. This article assesses how well the US FDA and the Australian TGA achieve this balance.